Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LHW090 in resistant hypertension
NL-OMON43264Phase 2Active, not recruiting
- Sponsor
- Novartis
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in resistant hypertension (RH) comparing LHW090 plus background antihypertensive therapy with Placebo plus background antihypertensive therapy (2 arms). Started Sep 2016; status: active, not recruiting.
02
Drugs
LHW090
03
Conditions
resistant hypertension (RH)
Beyond the preview
Go deeper on NL-OMON43264.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON43264.